Co-founder and Chief strategy officer recognized for establishing Proscia as a market leader
PHILADELPHIA – March 10, 2025 – The Georgia Institute of Technology’s College of Engineering has named Nathan Buchbinder among its 2025 Council of Outstanding Young Engineering Alumni awardees. Buchbinder, who received a master’s degree in biomedical innovation and development in 2016, was celebrated for his accomplishments as Co-founder and Chief Strategy Officer of Proscia® during a ceremony on March 8.
“I am honored that the College of Engineering has been following my journey,” said Buchbinder. “Beyond the knowledge that I gained in the classroom and conducting research, I grew comfortable solving complex problems during my time at Georgia Tech. This culture of leadership and innovation has shaped how I approach my career.”
Since Buchbinder co-founded Proscia in 2014, the company has emerged as a market leader in enterprise pathology, fueling the development and use of the next novel therapies and diagnostics with its Concentriq® software platform, AI, and real-world data. The company counts the pharmaceutical companies behind 34 of the 50 best-selling drugs among its users, and its laboratory customers are on track to diagnose over 8M patients on its software this year.
In his role as chief strategy officer, Buchbinder sits at the intersection of Proscia’s customers and products and the broader digital pathology community, overseeing strategic growth initiatives and leading its participation in industry initiatives. He also sits on the board of the Digital Pathology Association.
About Proscia
Proscia is a software company accelerating pathology’s transition to a digital, data-driven discipline and enabling AI to advance precision medicine. Its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fuel the development and use of novel therapies and diagnostics to drive the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia’s solutions each day. The company has FDA 510(k) clearance and CE-IVDR certification for its diagnostic software. For more information, visit proscia.com, and follow Proscia on LinkedIn and X.
